Biosimilar SB17 demonstrated clinical biosimilarity to reference ustekinumab after switching and maintained long-term ...
Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...
A real-world study in adolescent and young adult patients with inflammatory bowel disease (IBD) found no significant ...
The Top 5 Biosimilar Articles for the Week of December 2 ...
The Top 5 Biosimilar Articles for the Week of December 2 ...
When compared with reference aflibercept, a biosimilar ranibizumab was a clinically effective and cost-saving alternative in ...
The Top 5 Biosimilar Articles for the Week of December 2 ...
In 2024, the FDA approved 19 biosimilars across various therapeutic areas, including the first biosimilars for ustekinumab ...
The Top 5 Biosimilar Articles for the Week of December 2 ...
Sarfaraz K. Niazi, PhD, dives into the role that biosimilar associations and organizations play in promoting biosimilars as well as how their stakeholder demographic and main objectives differ from ...
The 3 largest pharmacy benefit managers (PBMs) increased many specialty generic drugs prices by hundreds of percent, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback